TipRanks
CDT Equity (CDT)
NASDAQ:CDT
US Market

Compare CDT Equity (CDT) vs. Competitors

423 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
CDT Equity
$1.89
$1.53M
―
-100.00%
―
Moleculin Biotech
$0.61
$10.20M
-0.03
-96.20%
3 Buy
0 Hold
0 Sell
Strong Buy
Bone Biologics
$0.62
$1.37M
-0.25
-82.97%
―
Silexion Therapeutics
$0.36
$3.06M
>-0.01
-99.26%
0 Buy
1 Hold
0 Sell
Hold
Calidi Biotherapeutics
$1.31
$3.93M
-0.02
-95.86%
―
Azitra Inc
$0.18
$8.34M
-0.11
-82.27%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CDT
CDT Equity
1.25
-33,968.75
-100.00%
MBRX
Moleculin Biotech
0.50
-12.00
-95.98%
BBLG
Bone Biologics
0.48
-2.07
-81.37%
SLXN
Silexion Therapeutics
0.28
-37.42
-99.26%
CLDI
Calidi Biotherapeutics
1.08
-23.88
-95.67%
AZTR
Azitra Inc
0.13
-0.61
-82.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts